ǿմý

Andrew T. Pavia
No Rating Available
(Learn About Our Rating System)

Andrew T. Pavia, MD

Languages spoken: English, Italian, French

Clinical Locations

Eccles Primary Children's Outpatient Services

Salt Lake City
801-213-3599

  • Dr. Pavia received his bachelor's degree and medical degree at Brown University. He trained in internal medicine and pediatrics at Dartmouth and the University of Utah. At the Centers for Disease Control and Prevention, Dr. Pavia trained in Public ǿմý Epidemiology as an Epidemic Intelligence Service (EIS) officer and a Preventive Medicine Resident. Additionally, Dr. Pavia completed a fellowship in pediatric and adult infectious diseases at the University of Utah. He joined the faculty at the University of Utah in 1991. In 2003 Dr. Pavia became the George and Esther Gross Presidential Professor and Chief of the Division of Pediatric Infectious Diseases, where he mentors a dynamic and productive team of faculty and fellows. He also serves as Director of Hospital Epidemiology at Primary Children's Hospital and Associate Director of Antimicrobial Stewardship. Dr. Pavia is a member of the Society for Pediatric Research. He is a Fellow of the American Academy of Pediatrics, the Infectious Diseases Society of America and the Society for ǿմýcare Epidemiology of America. Dr. Pavia is a member of the National Academy of Science Engineering and Medicine Forum on Preparedness. He was recently Vice Chair and Chair of the Program Committee for IDWeek and served two terms on the CDC Board of Scientific Counselors. He has served as a member of the Board of Directors the Infectious Disease Society of America (IDSA) and past chair of the Pandemic Influenza Task Force and past Chair of the National and Global Public Policy Committee. Dr. Pavia served as a member of the National Vaccine Advisory Committee and chaired the Vaccine Safety Working Group, was an inaugural member of the National Biodefense Science Board (NBSB) and chaired the Influenza Working Group, and co-chaired the Personal Preparedness Working Group of the NBSB from 2008-2010. Dr. Pavia has served on several Institute of Medicine Committees including “Antivirals for Pandemic Influenza: Guidance on Developing and Distribution and Dispensing System,” and “Prepositioned Medical Countermeasure for the Public,” and is a frequent consultant for CDC. He is an associate Editor of the Sanford Guide to Antimicrobial Therapy and is on the editorial board the Journal of the Pediatric Infectious Disease Society and a reviewer for numerous journals. He has published more than 250 peer-reviewed scientific articles, textbook chapters, reviews and scientific abstracts. His research interests include the epidemiology of influenza and other emerging respiratory infections, pneumonia, vaccine preventable diseases, emerging infections, and HIV/ AIDS, with a particular interest in infections of pregnant women and their children. He has been the principal investigator or co-investigator on grants from the National Institutes of ǿմý, the Bill and Melinda Gates Foundation, and the Centers for Disease Control and Prevention.

    Dr. Pavia received his undergraduate and medical degrees from Brown University. He completed his residency at Dartmouth Hitchcock Medical Center and served as Chief Resident. He then served as an officer in the Epidemic Intelligence Service at the Centers for Disease Control and Prevention and completed a residency in Preventive Medicine. He completed fellowship training in pediatric and adult infectious diseases at the University of Utah. Dr. Pavia is currently the George and Esther Gross Presidential Professor at the University of Utah and is Chief of the Division of Pediatric Infectious Diseases. His academic interests include the epidemiology, diagnosis and management of emerging infectious diseases including influenza, respiratory infections and diarrheal diseases. He is also keenly interested in HIV/AIDS and has been involved in HIV clinical care and research since the 1980’s.

    Specialties

    Board Certification

    American Board of Internal Medicine (Internal Medicine)

  • Dr. Pavia received his bachelor's degree and medical degree at Brown University. He trained in internal medicine and pediatrics at Dartmouth and the University of Utah. At the Centers for Disease Control and Prevention, Dr. Pavia trained in Public ǿմý Epidemiology as an Epidemic Intelligence Service (EIS) officer and a Preventive Medicine Resident. Additionally, Dr. Pavia completed a fellowship in pediatric and adult infectious diseases at the University of Utah. He joined the faculty at the University of Utah in 1991. In 2003 Dr. Pavia became the George and Esther Gross Presidential Professor and Chief of the Division of Pediatric Infectious Diseases, where he mentors a dynamic and productive team of faculty and fellows. He also serves as Director of Hospital Epidemiology at Primary Children's Hospital and Associate Director of Antimicrobial Stewardship. Dr. Pavia is a member of the Society for Pediatric Research. He is a Fellow of the American Academy of Pediatrics, the Infectious Diseases Society of America and the Society for ǿմýcare Epidemiology of America. Dr. Pavia is a member of the National Academy of Science Engineering and Medicine Forum on Preparedness. He was recently Vice Chair and Chair of the Program Committee for IDWeek and served two terms on the CDC Board of Scientific Counselors. He has served as a member of the Board of Directors the Infectious Disease Society of America (IDSA) and past chair of the Pandemic Influenza Task Force and past Chair of the National and Global Public Policy Committee. Dr. Pavia served as a member of the National Vaccine Advisory Committee and chaired the Vaccine Safety Working Group, was an inaugural member of the National Biodefense Science Board (NBSB) and chaired the Influenza Working Group, and co-chaired the Personal Preparedness Working Group of the NBSB from 2008-2010. Dr. Pavia has served on several Institute of Medicine Committees including “Antivirals for Pandemic Influenza: Guidance on Developing and Distribution and Dispensing System,” and “Prepositioned Medical Countermeasure for the Public,” and is a frequent consultant for CDC. He is an associate Editor of the Sanford Guide to Antimicrobial Therapy and is on the editorial board the Journal of the Pediatric Infectious Disease Society and a reviewer for numerous journals. He has published more than 250 peer-reviewed scientific articles, textbook chapters, reviews and scientific abstracts. His research interests include the epidemiology of influenza and other emerging respiratory infections, pneumonia, vaccine preventable diseases, emerging infections, and HIV/ AIDS, with a particular interest in infections of pregnant women and their children. He has been the principal investigator or co-investigator on grants from the National Institutes of ǿմý, the Bill and Melinda Gates Foundation, and the Centers for Disease Control and Prevention.

    Dr. Pavia received his undergraduate and medical degrees from Brown University. He completed his residency at Dartmouth Hitchcock Medical Center and served as Chief Resident. He then served as an officer in the Epidemic Intelligence Service at the Centers for Disease Control and Prevention and completed a residency in Preventive Medicine. He completed fellowship training in pediatric and adult infectious diseases at the University of Utah. Dr. Pavia is currently the George and Esther Gross Presidential Professor at the University of Utah and is Chief of the Division of Pediatric Infectious Diseases. His academic interests include the epidemiology, diagnosis and management of emerging infectious diseases including influenza, respiratory infections and diarrheal diseases. He is also keenly interested in HIV/AIDS and has been involved in HIV clinical care and research since the 1980’s.

    Board Certification and Academic Information

    Academic Departments Pediatrics -Primary
    Internal Medicine -Adjunct
    Academic Divisions Infectious Diseases
    Infectious Diseases
    Board Certification
    American Board of Internal Medicine (Internal Medicine)

    Education history

    Fellowship Adult/Pediatric Infectious Disease - University of Utah School of Medicine Fellow
    Residency Preventive Medicine - Centers for Disease Control and Prevention Resident
    Other Training Centers for Disease Control EIS
    Post Graduate Training Epidemiology - New England Epidemiology Institute Summer Program
    Chief Resident Internal Medicine - Dartmouth-Hitcock Medical Center Chief Resident
    Residency Internal Medicine - Dartmouth-Hitcock Medical Center Resident
    Internship Internal Medicine - Dartmouth-Hitcock Medical Center Intern
    Professional Medical Medicine - Brown University M.D.
    Undergraduate English Literature and Biology - Brown University A.B.

    Selected Publications

    Journal Article

    1. Murray JL, Leung DT, Hanson OR, Ahmed SM, Pavia AT, Khan AI, Szymczak JE, Vaughn VM, Patel PK, Biswas D, Watt MH (2024). Drivers of inappropriate use of antimicrobials in South Asia: A systematic review of qualitative literature. PLOS Glob Public ǿմý, 4(4), e0002507. ()
    2. Sartori LF, Nian H, Zhu Y, Johnson J, Stassun J, Ampofo K, Arnold DH, Antoon JW, Pavia AT, Grijalva CG, Williams DJ (2025). Removal of Race and White Blood Cell Count in an Updated Pediatric Pneumonia Severity Model. Hosp Pediatr, 14(3), e167-e169. ()
    3. Pavia AT, Cohen DM, Leber AL, Daly JA, Jackson JT, Selvarangan R, Kanwar N, Bender JM, Dien Bard J, Festekjian A, Duffy S, Larsen C, Holmberg KM, Bardsley T, Haaland B, Bourzac KM, Stockmann C, Chapin KC, Leung DT (2023). Clinical Impact of Multiplex Molecular Diagnostic Testing in Children With Acute Gastroenteritis Presenting to an Emergency Department: A Multicenter Prospective Study. Clin Infect Dis. ()
    4. Arnold SR, Jain S, Dansie D, Kan H, Williams DJ, Ampofo K, Anderson EJ, Grijalva CG, Bramley AM, Pavia AT, Edwards KM, Nolan VG, McCullers JA, Kaufman RA (2023). Association of Radiology Findings with Etiology of Community Acquired Pneumonia among Children. J Pediatr, 261, 113333. ()
    5. Antoon JW, Nian H, Ampofo K, Zhu Y, Sartori LF, Johnson J, Arnold DH, Stassun J, Pavia AT, Grijalva CG, Williams DJ (2022). Validation of Childhood Pneumonia Prognostic Models for Use in Emergency Care Settings. J Pediatric Infect Dis Soc, 12(8), 451-458. ()
    6. Williams DJ, Martin JM, Nian H, Weitkamp AO, Slagle J, Turer RW, Suresh S, Johnson J, Stassun J, Just SL, Reale C, Beebe R, Arnold DH, Antoon JW, Rixe NS, Sartori LF, Freundlich RE, Ampofo K, Pavia AT, Smith JC, Weinger MB, Zhu Y, Grijalva CG (2023). Antibiotic clinical decision support for pneumonia in the ED: A randomized trial. J Hosp Med, 18(6), 491-501. ()
    7. Freedman SB, Schnadower D, Estes M, Casper TC, Goldstein SL, Grisaru S, Pavia AT, Wilfond BS, Metheney M, Kimball K, Tarr PI, Hyperhydration to Improve Kidney Outcomes in children with Shiga Toxin-producing E Coli infection HIKO-STEC Study Team (2023). Hyperhydration to Improve Kidney Outcomes in Children with Shiga Toxin-Producing E. coli Infection: a multinational embedded cluster crossover randomized trial (the HIKO STEC trial). Trials, 24(1), 359. ()
    8. Kanwar N, Jackson J, Bardsley T, Pavia A, Bourzac KM, Holmberg K, Selvarangan R (2023). Impact of Rapid Molecular Multiplex Gastrointestinal Pathogen Testing in Management of Children during a Shigella Outbreak. J Clin Microbiol, 61(3), e0165222. ()
    9. Nelson EJ, Khan AI, Keita AM, Brintz BJ, Keita Y, Sanogo D, Islam MT, Khan ZH, Rashid MM, Nasrin D, Watt MH, Ahmed SM, Haaland B, Pavia AT, Levine AC, Chao DL, Kotloff KL, Qadri F, Sow SO, Leung DT (2022). Improving Antibiotic Stewardship for Diarrheal Disease With Probability-Based Electronic Clinical Decision Support: A Randomized Crossover Trial. JAMA Pediatr, 176(10), 973-979. ()
    10. Lee J, Zhu Y, Williams DJ, Self WH, Arnold SR, McCullers JA, Ampofo K, Pavia AT, Anderson EJ, Jain S, Edwards KM, Grijalva CG (2022). Red Blood Cell Distribution Width and Pediatric Community-Acquired Pneumonia Disease Severity. Hosp Pediatr, 12(9), 798-805. ()
    11. Greene C, Nian H, Zhu Y, Antoon JW, Freundlich KL, Ampofo K, Sartori LF, Johnson J, Arnold DH, Gesteland P, Stassun J, Robison J, Pavia AT, Grijalva CG, Williams DJ (2022). Associations between comorbidity-related functional limitations and pneumonia outcomes. J Hosp Med, 17(7), 527-533. ()
    12. Sekmen M, Johnson J, Zhu Y, Sartori LF, Grijalva CG, Stassun J, Arnold DH, Ampofo K, Robison J, Gesteland PH, Pavia AT, Williams DJ (2022). Association Between Procalcitonin and Antibiotics in Children With Community-Acquired Pneumonia. Hosp Pediatr, 12(4), 384-391. ()
    13. Kuriakose S, Singh K, Pau AK, Daar E, Gandhi R, Tebas P, Evans L, Gulick RM, Lane HC, Masur H, NIH COVID-19 Treatment Guidelines Panel, Aberg JA, Adimora AA, Baker J, Kreuziger LB, Bedimo R, Belperio PS, Cantrill SV, Coopersmith CM, Davis SL, Dzierba AL, Gallagher JJ, Glidden DV, Grund B, Hardy EJ, Hinkson C, Hughes BL, Johnson S, Keller MJ, Kim AY, Lennox JL, Levy MM, Li JZ, Martin GS, Naggie S, Pavia AT, Seam N, Simpson SQ, Swindells S, Tien P, Waghmare AA, Wilson KC, Yazdany J, Zachariah P, Campbell DM, Harrison C, Burgess T, Francis J, Sheikh V, Uyeki TM, Walker R, Brooks JT, Ortiz LB, Davey RT Jr, Doepel LK, Eisinger RW, Han A, Higgs ES, Nason MC, Crew P, Lerner AM, Lund C, Worthington C (2021). Developing Treatment Guidelines During a Pandemic ǿմý Crisis: Lessons Learned From COVID-19. Ann Intern Med, 174(8), 1151-1158. ()
    14. Schober ME, Pavia AT, Bohnsack JF (2021). Neurologic Manifestations of COVID-19 in Children: Emerging Pathophysiologic Insights. Pediatr Crit Care Med, 22(7), 655-661. ()
    15. Sartori LF, Zhu Y, Grijalva CG, Ampofo K, Gesteland P, Johnson J, McHenry R, Arnold DH, Pavia AT, Edwards KM, Williams DJ (2021). Pneumonia Severity in Children: Utility of Procalcitonin in Risk Stratification. Hosp Pediatr, 11(3), 215-222. ()
    16. Olson J, Mehra S, Hersh AL, Thorell EA, Stoddard GJ, Maese L, Barnette PE, Lemons RS, Pavia AT, Knackstedt ED (2019). Oral Step-Down Therapy With Levofloxacin for Febrile Neutropenia in Children With Cancer. J Pediatric Infect Dis Soc, 10(1), 27-33. ()
    17. Brintz BJ, Haaland B, Howard J, Chao DL, Proctor JL, Khan AI, Ahmed SM, Keegan LT, Greene T, Keita AM, Kotloff KL, Platts-Mills JA, Nelson EJ, Levine AC, Pavia AT, Leung DT (2021). A modular approach to integrating multiple data sources into real-time clinical prediction for pediatric diarrhea. Elife, 10. ()
    18. Howard LM, Edwards KM, Zhu Y, Grijalva CG, Self WH, Jain S, Ampofo K, Pavia AT, Arnold SR, McCullers JA, Anderson EJ, Wunderink RG, Williams DJ (2019). Clinical Features of Human Metapneumovirus-Associated Community-acquired Pneumonia Hospitalizations. Clin Infect Dis, 72(1), 108-117. ()
    19. Crandall H, Christiansen J, Varghese AA, Russon A, Korgenski EK, Bengtson EK, Dickey M, Killpack J, Knackstedt ED, Daly JA, Ampofo K, Pavia AT, Blaschke AJ (2019). Clinical and Molecular Epidemiology of Invasive Haemophilus influenzae Serotype a Infections in Utah Children. J Pediatric Infect Dis Soc, 9(6), 650-655. ()
    20. Brintz BJ, Howard JI, Haaland B, Platts-Mills JA, Greene T, Levine AC, Nelson EJ, Pavia AT, Kotloff KL, Leung DT (2020). Clinical predictors for etiology of acute diarrhea in children in resource-limited settings. PLoS Negl Trop Dis, 14(10), e0008677. ()
    21. Crandall H, Kapusta A, Killpack J, Heyrend C, Nilsson K, Dickey M, Daly JA, Ampofo K, Pavia AT, Mulvey MA, Yandell M, Hulten KG, Blaschke AJ (2020). Clinical and molecular epidemiology of invasive Staphylococcus aureus infection in Utah children; continued dominance of MSSA over MRSA. PLoS One, 15(9), e0238991. ()
    22. Howard LM, Edwards KM, Zhu Y, Williams DJ, Self WH, Jain S, Ampofo K, Pavia AT, Arnold SR, McCullers JA, Anderson EJ, Wunderink RG, Grijalva CG (2020). Parainfluenza Virus Types 1-3 Infections Among Children and Adults Hospitalized with Community-Acquired Pneumonia. Clin Infect Dis, 73, e4433-e4443. ()
    23. Hick JL, Hanfling D, Wynia MK, Pavia AT (2020). Duty to Plan: ǿմý Care, Crisis Standards of Care, and Novel Coronavirus SARS-CoV-2. NAM Perspect, 2020. ()
    24. Hughes MM, Carmack AE, McCaffrey K, Spencer M, Reed GM, Hill M, Dunn A, Risk I, Garg S, Reed C, Biggerstaff M, Mayer J, Gesteland P, Korgenski K, Dascomb K, Pavia A, Rolfes MA (2019). Estimating the Incidence of Influenza at the State Level - Utah, 2016-17 and 2017-18 Influenza Seasons. MMWR Morb Mortal Wkly Rep, 68(50), 1158-1161. ()
    25. Balch A, Wilkes J, Thorell E, Pavia A, Sherwin CMT, Enioutina EY (2019). Changing trends in IVIG use in pediatric patients: A retrospective review of practices in a network of major USA pediatric hospitals. Int Immunopharmacol, 76, 105868. ()
    26. Pavia A (2019). One hundred years after the 1918 pandemic: new concepts for preparing for influenza pandemics. Curr Opin Infect Dis, 32(4), 365-371. ()
    27. Fritz CQ, Edwards KM, Self WH, Grijalva CG, Zhu Y, Arnold SR, McCullers JA, Ampofo K, Pavia AT, Wunderink RG, Anderson EJ, Bramley AM, Jain S, Williams DJ (2019). Prevalence, Risk Factors, and Outcomes of Bacteremic Pneumonia in Children. Pediatrics, 144(1). ()
    28. Krah NM, Bardsley T, Nelson R, Esquibel L, Crosby M, Byington CL, Pavia AT, Hersh AL (2019). Economic Burden of Home Antimicrobial Therapy: OPAT Versus Oral Therapy. Hosp Pediatr, 9(4), 234-240. ()
    29. Uyeki TM, Bernstein HH, Bradley JS, Englund JA, File TM, Fry AM, Gravenstein S, Hayden FG, Harper SA, Hirshon JM, Ison MG, Johnston BL, Knight SL, McGeer A, Riley LE, Wolfe CR, Alexander PE, Pavia AT (2018). Clinical Practice Guidelines by the Infectious Diseases Society of America: 2018 Update on Diagnosis, Treatment, Chemoprophylaxis, and Institutional Outbreak Management of Seasonal Influenzaa. Clin Infect Dis, 68(6), e1-e47. ()
    30. Uyeki TM, Bernstein HH, Bradley JS, Englund JA, File TM, Fry AM, Gravenstein S, Hayden FG, Harper SA, Hirshon JM, Ison MG, Johnston BL, Knight SL, McGeer A, Riley LE, Wolfe CR, Alexander PE, Pavia AT (2018). Clinical Practice Guidelines by the Infectious Diseases Society of America: 2018 Update on Diagnosis, Treatment, Chemoprophylaxis, and Institutional Outbreak Management of Seasonal Influenzaa. Clin Infect Dis, 68(6), 895-902. ()
    31. Kutty PK, Jain S, Taylor TH, Bramley AM, Diaz MH, Ampofo K, Arnold SR, Williams DJ, Edwards KM, McCullers JA, Pavia AT, Winchell JM, Schrag SJ, Hicks LA (2018). Mycoplasma pneumoniae Among Children Hospitalized With Community-acquired Pneumonia. Clin Infect Dis, 68(1), 5-12. ()
    32. Frush JM, Zhu Y, Edwards KM, Grijalva CG, Thomsen IP, Self WH, Jain S, Anderson EJ, Ampofo K, Pavia AT, Arnold SR, McCullers JA, Williams DJ (2018). Prevalence of Staphylococcus aureus and Use of Antistaphylococcal Therapy in Children Hospitalized with Pneumonia. J Hosp Med, 13(12), 848-852. ()
    33. Coon ER, Srivastava R, Stoddard G, Wilkes J, Pavia AT, Shah SS (2018). Shortened IV Antibiotic Course for Uncomplicated, Late-Onset Group B Streptococcal Bacteremia. Pediatrics, 142(5). ()
    34. Stenehjem E, Hersh AL, Buckel WR, Jones P, Sheng X, Evans RS, Burke JP, Lopansri BK, Srivastava R, Greene T, Pavia AT (2018). Impact of Implementing Antibiotic Stewardship Programs in 15 Small Hospitals: A Cluster-Randomized Intervention. Clin Infect Dis, 67(4), 525-532. ()
    35. Adler FR, Stockmann C, Ampofo K, Pavia AT, Byington CL (2018). Transmission of rhinovirus in the Utah BIG-LoVE families: Consequences of age and household structure. PLoS One, 13(7), e0199388. ()
    36. Nolan VG, Arnold SR, Bramley AM, Ampofo K, Williams DJ, Grijalva CG, Self WH, Anderson EJ, Wunderink RG, Edwards KM, Pavia AT, Jain S, McCullers JA (2017). Etiology and Impact of Coinfections in Children Hospitalized With Community-Acquired Pneumonia. J Infect Dis, 218(2), 179-188. ()
    37. Kabbani S, Hersh AL, Shapiro DJ, Fleming-Dutra KE, Pavia AT, Hicks LA (2018). Opportunities to Improve Fluoroquinolone Prescribing in the United States for Adult Ambulatory Care Visits. Clin Infect Dis, 67(1), 134-136. ()
    38. Hersh AL, Olson J, Stockmann C, Thorell EA, Knackstedt ED, Esquibel L, Sanderson S, Pavia AT (2017). Impact of Antimicrobial Stewardship for Pediatric Outpatient Parenteral Antibiotic Therapy. J Pediatric Infect Dis Soc, 7(2), e34-e36. ()
    39. Krah NM, Olson J, Thorell EA, Esquibel L, Osguthorpe RJ, Pavia AT, Hersh AL (2018). Outpatient Parenteral Antimicrobial Therapy in Young Infants. J Pediatric Infect Dis Soc, 7(2), e40-e42. ()
    40. Bozio CH, Flanders WD, Finelli L, Bramley AM, Reed C, Gandhi NR, Vidal JE, Erdman D, Levine MZ, Lindstrom S, Ampofo K, Arnold SR, Self WH, Williams DJ, Grijalva CG, Anderson EJ, McCullers JA, Edwards KM, Pavia AT, Wunderink RG, Jain S (2018). Use of Multiple Imputation to Estimate the Proportion of Respiratory Virus Detections Among Patients Hospitalized With Community-Acquired Pneumonia. Open Forum Infect Dis, 5(4), ofy061. ()
    41. Hersh AL, Shapiro DJ, Pavia AT, Fleming-Dutra KE, Hicks LA (2017). Geographic Variability in Diagnosis and Antibiotic Prescribing for Acute Respiratory Tract Infections. Infect Dis Ther, 7(1), 171-174. ()
    42. Stockmann C, Ampofo K, Killpack J, Williams DJ, Edwards KM, Grijalva CG, Arnold SR, McCullers JA, Anderson EJ, Wunderink RG, Self WH, Bramley A, Jain S, Pavia AT, Blaschke AJ (2017). Procalcitonin Accurately Identifies Hospitalized Children With Low Risk of Bacterial Community-Acquired Pneumonia. J Pediatric Infect Dis Soc, 7(1), 46-53. ()
    43. Blaschke AJ, Korgenski EK, Wilkes J, Presson AP, Thorell EA, Pavia AT, Knackstedt ED, Reynolds C, Schunk JE, Daly JA, Byington CL (2018). Rhinovirus in Febrile Infants and Risk of Bacterial Infection. Pediatrics, 141(2). ()
    44. Williams DJ, Edwards KM, Self WH, Zhu Y, Arnold SR, McCullers JA, Ampofo K, Pavia AT, Anderson EJ, Hicks LA, Bramley AM, Jain S, Grijalva CG (2017). Effectiveness of β-Lactam Monotherapy vs Macrolide Combination Therapy for Children Hospitalized With Pneumonia. JAMA Pediatr, 171(12), 1184-1191. ()
    45. Lu X, Schneider E, Jain S, Bramley AM, Hymas W, Stockmann C, Ampofo K, Arnold SR, Williams DJ, Self WH, Patel A, Chappell JD, Grijalva CG, Anderson EJ, Wunderink RG, McCullers JA, Edwards KM, Pavia AT, Erdman DD (2017). Rhinovirus Viremia in Patients Hospitalized With Community-Acquired Pneumonia. J Infect Dis, 216(9), 1104-1111. ()
    46. Schlaberg R, Ampofo K, Tardif KD, Stockmann C, Simmon KE, Hymas W, Flygare S, Kennedy B, Blaschke A, Eilbeck K, Yandell M, McCullers JA, Williams DJ, Edwards K, Arnold SR, Bramley A, Jain S, Pavia AT (2017). Human Bocavirus Capsid Messenger RNA Detection in Children With Pneumonia. J Infect Dis, 216(6), 688-696. ()
    47. Stockmann C, Pavia AT, Graham B, Vaughn M, Crisp R, Poritz MA, Thatcher S, Korgenski EK, Barney T, Daly J, Rogatcheva M (2016). Detection of 23 Gastrointestinal Pathogens Among Children Who Present With Diarrhea. J Pediatric Infect Dis Soc, 6(3), 231-238. ()
    48. Bramley AM, Reed C, Finelli L, Self WH, Ampofo K, Arnold SR, Williams DJ, Grijalva CG, Anderson EJ, Stockmann C, Trabue C, Fakhran S, Balk R, McCullers JA, Pavia AT, Edwards KM, Wunderink RG, Jain S, Centers for Disease Control and Prevention Etiology of Pneumonia in the Community EPIC Study Team (2017). Relationship Between Body Mass Index and Outcomes Among Hospitalized Patients With Community-Acquired Pneumonia. J Infect Dis, 215(12), 1873-1882. ()
    49. Pavia AT (2017). Reducing diagnostic uncertainty to improve treatment of respiratory infections. Lancet Respir Med, 5(5), 364-365. ()
    50. Schlaberg R, Queen K, Simmon K, Tardif K, Stockmann C, Flygare S, Kennedy B, Voelkerding K, Bramley A, Zhang J, Eilbeck K, Yandell M, Jain S, Pavia AT, Tong S, Ampofo K (2017). Viral Pathogen Detection by Metagenomics and Pan-Viral Group Polymerase Chain Reaction in Children With Pneumonia Lacking Identifiable Etiology. J Infect Dis, 215(9), 1407-1415. ()
    51. Delgado-Corcoran C, Van Dorn CS, Pribble C, Thorell EA, Pavia AT, Ward C, Smout R, Bratton SL, Burch PT (2017). Reducing Pediatric Sternal Wound Infections: A Quality Improvement Project. Pediatr Crit Care Med, 18(5), 461-468. ()
    52. Stockmann C, Byington CL, Pavia AT, Ampofo K, Wilkes J, Korgenski EK, Hersh AL (2017). Limited and Variable Use of Antivirals for Children Hospitalized With Influenza. JAMA Pediatr, 171(3), 299-301. ()
    53. Harris AM, Bramley AM, Jain S, Arnold SR, Ampofo K, Self WH, Williams DJ, Anderson EJ, Grijalva CG, McCullers JA, Pavia AT, Wunderink RG, Edwards KM, Winchell JM, Hicks LA (2017). Influence of Antibiotics on the Detection of Bacteria by Culture-Based and Culture-Independent Diagnostic Tests in Patients Hospitalized With Community-Acquired Pneumonia. Open Forum Infect Dis, 4(1), ofx014. ()
    54. Zhang Y, Sakthivel SK, Bramley A, Jain S, Haynes A, Chappell JD, Hymas W, Lenny N, Patel A, Qi C, Ampofo K, Arnold SR, Self WH, Williams DJ, Hillyard D, Anderson EJ, Grijalva CG, Zhu Y, Wunderink RG, Edwards KM, Pavia AT, McCullers JA, Erdman DD (2017). Serology Enhances Molecular Diagnosis of Respiratory Virus Infections Other than Influenza in Children and Adults Hospitalized with Community-Acquired Pneumonia. J Clin Microbiol, 55(1), 79-89. ()
    55. Oboho IK, Bramley A, Finelli L, Fry A, Ampofo K, Arnold SR, Self WH, Williams DJ, Courtney DM, Zhu Y, Anderson EJ, Grijalva CG, McCullers JA, Wunderink RG, Pavia AT, Edwards KM, Jain S (2017). Oseltamivir Use Among Children and Adults Hospitalized With Community-Acquired Pneumonia. Open Forum Infect Dis, 4(1), ofw254. ()
    56. Veesenmeyer AF, Olson JA, Hersh AL, Stockmann C, Korgenski K, Thorell EA, Pavia AT, Blaschke AJ (2016). A Retrospective Study of the Impact of Rapid Diagnostic Testing on Time to Pathogen Identification and Antibiotic Use for Children with Positive Blood Cultures. Infect Dis Ther, 5(4), 555-570. ()
    57. Stenehjem E, Hersh AL, Sheng X, Jones P, Buckel WR, Lloyd JF, Howe S, Evans RS, Greene T, Pavia AT (2016). Antibiotic Use in Small Community Hospitals. Clin Infect Dis, 63(10), 1273-1280. ()
    58. Williams DJ, Zhu Y, Grijalva CG, Self WH, Harrell FE Jr, Reed C, Stockmann C, Arnold SR, Ampofo KK, Anderson EJ, Bramley AM, Wunderink RG, McCullers JA, Pavia AT, Jain S, Edwards KM (2016). Predicting Severe Pneumonia Outcomes in Children. Pediatrics, 138(4). ()
    59. Stockmann C, Ampofo K, Pavia AT, Blaschke AJ, Mason EO, Presson AP, Forney LJ, Byington CL (2016). Clinical and Epidemiological Evidence of the Red Queen Hypothesis in Pneumococcal Serotype Dynamics. Clin Infect Dis, 63(5), 619-626. ()
    60. Davis CR, Stockmann C, Pavia AT, Byington CL, Blaschke AJ, Hersh AL, Thorell EA, Korgenski K, Daly J, Ampofo K (2015). Incidence, Morbidity, and Costs of Human Metapneumovirus Infection in Hospitalized Children. J Pediatric Infect Dis Soc, 5(3), 303-11. ()
    61. Shakib JH, Korgenski K, Presson AP, Sheng X, Varner MW, Pavia AT, Byington CL (2016). Influenza in Infants Born to Women Vaccinated During Pregnancy. Pediatrics, 137(6). ()
    62. Schwab EM, Wilkes J, Korgenski K, Hersh AL, Pavia AT, Stevens VW (2016). Risk Factors for Recurrent Clostridium difficile Infection in Pediatric Inpatients. Hosp Pediatr, 6(6), 339-44. ()
    63. Millman AJ, Finelli L, Bramley AM, Peacock G, Williams DJ, Arnold SR, Grijalva CG, Anderson EJ, McCullers JA, Ampofo K, Pavia AT, Edwards KM, Jain S (2016). Community-Acquired Pneumonia Hospitalization among Children with Neurologic Disorders. J Pediatr, 173, 188-195.e4. ()
    64. Diaz MH, Cross KE, Benitez AJ, Hicks LA, Kutty P, Bramley AM, Chappell JD, Hymas W, Patel A, Qi C, Williams DJ, Arnold SR, Ampofo K, Self WH, Grijalva CG, Anderson EJ, McCullers JA, Pavia AT, Wunderink RG, Edwards KM, Jain S, Winchell JM (2016). Identification of Bacterial and Viral Codetections With Mycoplasma pneumoniae Using the TaqMan Array Card in Patients Hospitalized With Community-Acquired Pneumonia. Open Forum Infect Dis, 3(2), ofw071. ()
    65. Self WH, Williams DJ, Zhu Y, Ampofo K, Pavia AT, Chappell JD, Hymas WC, Stockmann C, Bramley AM, Schneider E, Erdman D, Finelli L, Jain S, Edwards KM, Grijalva CG (2016). Respiratory Viral Detection in Children and Adults: Comparing Asymptomatic Controls and Patients With Community-Acquired Pneumonia. J Infect Dis, 213(4), 584-91. ()
    66. Buckel WR, Hersh AL, Pavia AT, Jones PS, Owen-Smith AA, Stenehjem E (2016). Antimicrobial Stewardship Knowledge, Attitudes, and Practices among ǿմý Care Professionals at Small Community Hospitals. Hosp Pharm, 51(2), 149-157. ()
    67. Leung DT, Chisti MJ, Pavia AT (2016). Prevention and Control of Childhood Pneumonia and Diarrhea. Pediatr Clin North Am, 63(1), 67-79. ()
    68. Kendall BA, Dascomb KK, Mehta RR, Stockmann C, Mason EO, Ampofo K, Pavia AT, Byington CL (2016). Early Streptococcus pneumoniae serotype changes in Utah adults after the introduction of PCV13 in children. Vaccine, 34(4), 474-478. ()
    69. Stockmann C, Ampofo K, Pavia AT, Byington CL, Sheng X, Greene TH, Korgenski EK, Hersh AL (2015). Comparative Effectiveness of Oral Versus Outpatient Parenteral Antibiotic Therapy for Empyema. Hosp Pediatr, 5(12), 605-12. ()
    70. Byington CL, Ampofo K, Stockmann C, Adler FR, Herbener A, Miller T, Sheng X, Blaschke AJ, Crisp R, Pavia AT (2015). Community Surveillance of Respiratory Viruses Among Families in the Utah Better Identification of Germs-Longitudinal Viral Epidemiology (BIG-LoVE) Study. Clin Infect Dis, 61(8), 1217-24. ()
    71. Grijalva CG, Zhu Y, Williams DJ, Self WH, Ampofo K, Pavia AT, Stockmann CR, McCullers J, Arnold SR, Wunderink RG, Anderson EJ, Lindstrom S, Fry AM, Foppa IM, Finelli L, Bramley AM, Jain S, Griffin MR, Edwards KM (2015). Association Between Hospitalization With Community-Acquired Laboratory-Confirmed Influenza Pneumonia and Prior Receipt of Influenza Vaccination. JAMA, 314(14), 1488-97. ()
    72. Ahn A, Edwards KM, Grijalva CG, Self WH, Zhu Y, Chappell JD, Arnold SR, McCullers JA, Ampofo K, Pavia AT, Bramley AM, Jain S, Williams DJ (2015). Secondhand Smoke Exposure and Illness Severity among Children Hospitalized with Pneumonia. J Pediatr, 167(4), 869-874.e1. ()
    73. Grijalva CG, Wunderink RG, Zhu Y, Williams DJ, Balk R, Fakhran S, Courtney DM, Anderson EJ, Qi C, Trabue C, Pavia AT, Moore MR, Jain S, Edwards KM, Self WH (2015). In-Hospital Pneumococcal Polysaccharide Vaccination Is Associated With Detection of Pneumococcal Vaccine Serotypes in Adults Hospitalized for Community-Acquired Pneumonia. Open Forum Infect Dis, 2(4), ofv135. ()
    74. Spivak ES, Kendall B, Orlando P, Perez C, De Amorim M, Samore M, Pavia AT, Hersh AL (2015). Evaluation of Outpatient Parenteral Antimicrobial Therapy at a Veterans Affairs Hospital. Infect Control Hosp Epidemiol, 36(9), 1103-5. ()
    75. Diaz MH, Benitez AJ, Cross KE, Hicks LA, Kutty P, Bramley AM, Chappell JD, Hymas W, Patel A, Qi C, Williams DJ, Arnold SR, Ampofo K, Self WH, Grijalva CG, Anderson EJ, McCullers JA, Pavia AT, Wunderink RG, Edwards KM, Jain S, Winchell JM (2015). Molecular Detection and Characterization of Mycoplasma pneumoniae Among Patients Hospitalized With Community-Acquired Pneumonia in the United States. Open Forum Infect Dis, 2(3), ofv106. ()
    76. Pillai SK, Beekmann SE, Babcock HM, Pavia AT, Koonin LM, Polgreen PM (2015). Clinician Beliefs and Attitudes Regarding Use of Respiratory Protective Devices and Surgical Masks for Influenza. ǿմý Secur, 13(4), 274-80. ()
    77. Williams DJ, Edwards KM, Self WH, Zhu Y, Ampofo K, Pavia AT, Hersh AL, Arnold SR, McCullers JA, Hicks LA, Bramley AM, Jain S, Grijalva CG (2015). Antibiotic Choice for Children Hospitalized With Pneumonia and Adherence to National Guidelines. Pediatrics, 136(1), 44-52. ()
    78. Stockmann C, Ampofo K, Pavia AT, Byington CL, Blaschke AJ, Sherwin CM, Spigarelli MG, Hersh AL (2015). National trends in the incidence, outcomes and charges of pediatric osteoarticular infections, 1997-2012. Pediatr Infect Dis J, 34(6), 672-4. ()
    79. Nelson RE, Stockmann C, Hersh AL, Pavia AT, Korgenksi K, Daly JA, Couturier MR, Ampofo K, Thorell EA, Doby EH, Robison JA, Blaschke AJ (2015). Economic analysis of rapid and sensitive polymerase chain reaction testing in the emergency department for influenza infections in children. Pediatr Infect Dis J, 34(6), 577-82. ()
    80. Bender JM, Virgallito M, Newland JG, Sammons JS, Thorell EA, Coffin SE, Pavia AT, Sandora TJ, Hersh AL (2015). Infection prevention and control practices in children's hospitals. Infect Control Hosp Epidemiol, 36(5), 597-600. ()
    81. Hersh AL, Gerber JS, Hicks LA, Pavia AT (2015). Lessons Learned in Antibiotic Stewardship: Fluoroquinolone Use in Pediatrics. J Pediatric Infect Dis Soc, 4(1), 57-9. ()
    82. Jain S, Williams DJ, Arnold SR, Ampofo K, Bramley AM, Reed C, Stockmann C, Anderson EJ, Grijalva CG, Self WH, Zhu Y, Patel A, Hymas W, Chappell JD, Kaufman RA, Kan JH, Dansie D, Lenny N, Hillyard DR, Haynes LM, Levine M, Lindstrom S, Winchell JM, Katz JM, Erdman D, Schneider E, Hicks LA, Wunderink RG, Edwards KM, Pavia AT, McCullers JA, Finelli L, CDC EPIC Study Team (2015). Community-acquired pneumonia requiring hospitalization among U.S. children. N Engl J Med, 372(9), 835-45. ()
    83. Knackstedt ED, Stockmann C, Davis CR, Thorell EA, Pavia AT, Hersh AL (2015). Outpatient parenteral antimicrobial therapy in pediatrics: an opportunity to expand antimicrobial stewardship. Infect Control Hosp Epidemiol, 36(2), 222-4. ()
    84. Stockmann C, Rogatcheva M, Harrel B, Vaughn M, Crisp R, Poritz M, Thatcher S, Korgenski EK, Barney T, Daly J, Pavia AT (2015). How well does physician selection of microbiologic tests identify Clostridium difficile and other pathogens in paediatric diarrhoea? Insights using multiplex PCR-based detection. Clin Microbiol Infect, 21(2), 179.e9-15. ()
    85. Stockmann C, Pavia AT, Hersh AL, Spigarelli MG, Castle B, Korgenski K, Byington CL, Ampofo K (2014). Age-Specific Patterns of Influenza Activity in Utah: Do Older School Age Children Drive the Epidemic? J Pediatric Infect Dis Soc, 3(2), 163-7. ()
    86. Blaschke AJ, Shapiro DJ, Pavia AT, Byington CL, Ampofo K, Stockmann C, Hersh AL (2014). A National Study of the Impact of Rapid Influenza Testing on Clinical Care in the Emergency Department. J Pediatric Infect Dis Soc, 3(2), 112-8. ()
    87. Bradley JS, Peacock G, Krug SE, Bower WA, Cohn AC, Meaney-Delman D, Pavia AT, AAP Committee on Infectious Diseases and Disaster Preparedness Advisory Council (2014). Pediatric anthrax clinical management. Pediatrics, 133(5), e1411-36. ()
    88. Bradley JS, Peacock G, Krug SE, Bower WA, Cohn AC, Meaney-Delman D, Pavia AT, AAP Committee on Infectious Diseases and Disaster Preparedness Advisory Council (2014). Pediatric anthrax clinical management: executive summary. Pediatrics, 133(5), 940-2. ()
    89. Shapiro DJ, Hicks LA, Pavia AT, Hersh AL (2014). Antibiotic prescribing for adults in ambulatory care in the USA, 2007-09. J Antimicrob Chemother, 69(1), 234-40. ()
    90. Shakib JH, Korgenski K, Sheng X, Varner MW, Pavia AT, Byington CL (2013). Tetanus, diphtheria, acellular pertussis vaccine during pregnancy: pregnancy and infant health outcomes. J Pediatr, 163(5), 1422-6.e1-4. ()
    91. Stockmann C, Ampofo K, Byington CL, Filloux F, Hersh AL, Blaschke AJ, Cowan P, Korgenski K, Mason EO, Pavia AT (2013). Pneumococcal meningitis in children: epidemiology, serotypes, and outcomes from 1997-2010 in Utah. Pediatrics, 132(3), 421-8. ()
    92. Pavia AT (2013). Influenza A(H7N9): from anxiety to preparedness. Ann Intern Med, 159(3), 219-20. ()
    93. Stockmann C, Sherwin CM, Ampofo K, Hersh AL, Pavia AT, Byington CL, Ward RM, Spigarelli MG (2013). Characteristics of antimicrobial studies registered in the USA through ClinicalTrials.Gov. Int J Antimicrob Agents, 42(2), 161-6. ()
    94. Olarte L, Ampofo K, Stockmann C, Mason EO, Daly JA, Pavia AT, Byington CL (2013). Invasive pneumococcal disease in infants younger than 90 days before and after introduction of PCV7. Pediatrics, 132(1), e17-24. ()
    95. Stockmann C, Ampofo K, Hersh AL, Carleton ST, Korgenski K, Sheng X, Pavia AT, Byington CL (2013). Seasonality of acute otitis media and the role of respiratory viral activity in children. Pediatr Infect Dis J, 32(4), 314-9. ()
    96. Pavia AT (2013). What is the role of respiratory viruses in community-acquired pneumonia?: What is the best therapy for influenza and other viral causes of community-acquired pneumonia? Infect Dis Clin North Am, 27(1), 157-75. ()
    97. Blaschke AJ, Heyrend C, Byington CL, Fisher MA, Barker E, Garrone NF, Thatcher SA, Pavia AT, Barney T, Alger GD, Daly JA, Ririe KM, Ota I, Poritz MA (2012). Rapid identification of pathogens from positive blood cultures by multiplex polymerase chain reaction using the FilmArray system. Diagn Microbiol Infect Dis, 74(4), 349-55. ()
    98. Guerra AH, Stockmann C, Pavia AT, Hersh AL, Thorell EA, Weng HY, Korgenski K, Byington CL, Ampofo K (2012). Laboratory-Confirmed Rotavirus Disease in Utah Children: Clinical and Economic Impact of Rotavirus Vaccination. J Pediatric Infect Dis Soc, 1(4), 268-77. ()
    99. Stockmann C, Ampofo K, Hersh AL, Blaschke AJ, Kendall BA, Korgenski K, Daly J, Hill HR, Byington CL, Pavia AT (2012). Evolving epidemiologic characteristics of invasive group a streptococcal disease in Utah, 2002-2010. Clin Infect Dis, 55(4), 479-87. ()
    100. Byington CL, Reynolds CC, Korgenski K, Sheng X, Valentine KJ, Nelson RE, Daly JA, Osguthorpe RJ, James B, Savitz L, Pavia AT, Clark EB (2012). Costs and infant outcomes after implementation of a care process model for febrile infants. Pediatrics, 130(1), e16-24. ()
    101. Doby EH, Benjamin DK Jr, Blaschke AJ, Ward RM, Pavia AT, Martin PL, Driscoll TA, Cohen-Wolkowiez M, Moran C (2012). Therapeutic monitoring of voriconazole in children less than three years of age: a case report and summary of voriconazole concentrations for ten children. Pediatr Infect Dis J, 31(6), 632-5. ()
    102. Olarte L, Ampofo K, Thorell EA, Sanderson S, Doby E, Pavia AT, Rosado H, Raoult D, Socolovschi C, Hersh AL (2012). Bartonella vinsonii endocarditis in an adolescent with congenital heart disease. Pediatr Infect Dis J, 31(5), 531-4. ()
    103. Pavia AT (2012). Laboratory creation of a highly transmissible H5N1 influenza virus: balancing substantial risks and real benefits. Ann Intern Med, 156(6), 463-5. ()
    104. Ampofo K, Pavia AT, Chris S, Hersh AL, Bender JM, Blaschke AJ, Weng HY, Korgenski KE, Daly J, Mason EO, Byington CL (2012). The changing epidemiology of invasive pneumococcal disease at a tertiary children's hospital through the 7-valent pneumococcal conjugate vaccine era: a case for continuous surveillance. Pediatr Infect Dis J, 31(3), 228-34. ()
    105. Hersh AL, Shapiro DJ, Pavia AT, Shah SS (2011). Antibiotic prescribing in ambulatory pediatrics in the United States. Pediatrics, 128(6), 1053-61. ()
    106. Ampofo K, Pavia AT, Stockmann CR, Blaschke AJ, Weng HY, Korgenski KE, Daly J, Byington CL (2011). Evolution of the epidemiology of pneumococcal disease among Utah children through the vaccine era. Pediatr Infect Dis J, 30(12), 1100-3. ()
    107. Ampofo K, Pavia AT, Stockmann C, Hersh AL, Bender JM, Blaschke AJ, Weng HY, Korgenski KE, Daly J, Mason EO, Byington CL (2011). The Changing Epidemiology of Invasive Pneumococcal Disease at a Tertiary Children's Hospital through the PCV7 Era. Pediatr Infect Dis J. ()
    108. Kendall BA, Dascomb KK, Mehta RR, Mason EO, Ampofo K, Pombo DJ, Pavia AT, Byington CL (2011). Streptococcus pneumoniae serotypes in Utah adults at the end of the PCV7 era. Vaccine, 29(49), 9123-6. ()
    109. Hersh AL, Herigon JC, Ampofo K, Pavia AT, Newland JG (2011). Rapid increase in use of antiviral therapy for hospitalized children with influenza during the 2009 H1N1 epidemic. Pediatr Infect Dis J, 30(10), 895-7. ()
    110. Rubach MP, Bender JM, Mottice S, Hanson K, Weng HY, Korgenski K, Daly JA, Pavia AT (2011). Increasing incidence of invasive Haemophilus influenzae disease in adults, Utah, USA. Emerg Infect Dis, 17(9), 1645-50. ()
    111. Pavia AT (2011). Viral infections of the lower respiratory tract: old viruses, new viruses, and the role of diagnosis. Clin Infect Dis, 52 Suppl 4, S284-9. ()
    112. Blaschke AJ, Heyrend C, Byington CL, Obando I, Vazquez-Barba I, Doby EH, Korgenski EK, Sheng X, Poritz MA, Daly JA, Mason EO, Pavia AT, Ampofo K (2011). Molecular analysis improves pathogen identification and epidemiologic study of pediatric parapneumonic empyema. Pediatr Infect Dis J, 30(4), 289-94. ()
    113. Staes CJ, Wuthrich A, Gesteland P, Allison MA, Leecaster M, Shakib JH, Carter ME, Mallin BM, Mottice S, Rolfs R, Pavia AT, Wallace B, Gundlapalli AV, Samore M, Byington CL (2011). Public health communication with frontline clinicians during the first wave of the 2009 influenza pandemic. J Public ǿմý Manag Pract, 17(1), 36-44. ()
    114. Ampofo K, Herbener A, Blaschke AJ, Heyrend C, Poritz M, Korgenski K, Rolfs R, Jain S, Carvalho Mda G, Pimenta FC, Daly J, Mason EO, Byington CL, Pavia AT (2010). Association of 2009 pandemic influenza A (H1N1) infection and increased hospitalization with parapneumonic empyema in children in Utah. Pediatr Infect Dis J, 29(10), 905-9. ()
    115. Bender JM, Ampofo K, Byington CL, Grinsell M, Korgenski K, Daly JA, Mason EO, Pavia AT (2010). Epidemiology of Streptococcus pneumoniae-induced hemolytic uremic syndrome in Utah children. Pediatr Infect Dis J, 29(8), 712-6. ()
    116. Allison MA, Guest-Warnick G, Nelson D, Pavia AT, Srivastava R, Gesteland PH, Rolfs RT, Andersen S, Calame L, Young P, Byington CL (2010). Feasibility of elementary school children's use of hand gel and facemasks during influenza season. Influenza Other Respir Viruses, 4(4), 223-9. ()
    117. Couturier BA, Bender JM, Schwarz MA, Pavia AT, Hanson KE, She RC (2010). Oseltamivir-resistant influenza A 2009 H1N1 virus in immunocompromised patients. Influenza Other Respir Viruses, 4(4), 199-204. ()
    118. Ison MG, de Jong MD, Gilligan KJ, Higgs ES, Pavia AT, Pierson J, Hayden FG (2010). End points for testing influenza antiviral treatments for patients at high risk of severe and life-threatening disease. J Infect Dis, 201(11), 1654-62. ()
    119. Bender JM, Cox CM, Mottice S, She RC, Korgenski K, Daly JA, Pavia AT (2010). Invasive Haemophilus influenzae disease in Utah children: an 11-year population-based study in the era of conjugate vaccine. Clin Infect Dis, 50(7), e41-6. ()
    120. Byington CL, Hulten KG, Ampofo K, Sheng X, Pavia AT, Blaschke AJ, Pettigrew M, Korgenski K, Daly J, Mason EO (2010). Molecular epidemiology of pediatric pneumococcal empyema from 2001 to 2007 in Utah. J Clin Microbiol, 48(2), 520-5. ()
    121. Bender JM, Ampofo K, Gesteland P, Sheng X, Korgenski K, Raines B, Daly JA, Valentine K, Srivastava R, Pavia AT, Byington CL (2010). Influenza virus infection in infants less than three months of age. Pediatr Infect Dis J, 29(1), 6-9. ()
    122. Blaschke AJ, Korgenski EK, Daly JA, LaFleur B, Pavia AT, Byington CL (2009). Extended-spectrum beta-lactamase-producing pathogens in a children's hospital: a 5-year experience. Am J Infect Control, 37(6), 435-41. ()
    123. Powers AE, Bender JM, Kumnovics A, Ampofo K, Augustine N, Pavia AT, Hill HR (2009). Coccidioides immitis meningitis in a patient with hyperimmunoglobulin E syndrome due to a novel mutation in signal transducer and activator of transcription. Pediatr Infect Dis J, 28(7), 664-6. ()
    124. Bender JM, Rand TH, Ampofo K, Pavia AT, Schober M, Tebo A, Pasi B, Augustine NH, Pryor RJ, Wittwer CT, Hill HR (2009). Family clusters of variant X-linked chronic granulomatous disease. Pediatr Infect Dis J, 28(6), 529-33. ()
    125. Bender JM, Ampofo K, Gesteland P, Stoddard GJ, Nelson D, Byington CL, Pavia AT, Srivastava R (2009). Development and validation of a risk score for predicting hospitalization in children with influenza virus infection. Pediatr Emerg Care, 25(6), 369-75. ()
    126. Harper SA, Bradley JS, Englund JA, File TM, Gravenstein S, Hayden FG, McGeer AJ, Neuzil KM, Pavia AT, Tapper ML, Uyeki TM, Zimmerman RK, Expert Panel of the Infectious Diseases Society of America (2009). Seasonal influenza in adults and children--diagnosis, treatment, chemoprophylaxis, and institutional outbreak management: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis, 48(8), 1003-32. ()
    127. National Vaccine Advisory Committee, Stokley S, Freed G, Curtis R, Gordon L, Humiston S, Parnell T, Pavia A, Young A, Johnson D, Kennedy A, Hopfensperger D, Markowitz L, Fergie J, Koslap-Petraco MB, McCauley M (2009). Adolescent vaccination: recommendations from the National Vaccine Advisory Committee. Am J Prev Med, 36(3), 278-9.e6. ()
    128. Bender JM, Ampofo K, Sheng X, Pavia AT, Cannon-Albright L, Byington CL (2009). Parapneumonic empyema deaths during past century, Utah. Emerg Infect Dis, 15(1), 44-8. ()
    129. Keller M, Pavia AT, Byington CL (2008). Possible intrafamilial transmission of Toxocara causing eosinophilic meningitis in an infant. Pediatr Infect Dis J, 27(9), 849-50. ()
    130. Ampofo K, Bender J, Sheng X, Korgenski K, Daly J, Pavia AT, Byington CL (2008). Seasonal invasive pneumococcal disease in children: role of preceding respiratory viral infection. Pediatrics, 122(2), 229-37. ()
    131. Byington CL, Bender JM, Ampofo K, Pavia AT, Korgenski K, Daly J, Christenson JC, Adderson E (2008). Tularemia with vesicular skin lesions may be mistaken for infection with herpes viruses. Clin Infect Dis, 47(1), e4-6. ()
    132. Bender JM, Ampofo K, Korgenski K, Daly J, Pavia AT, Mason EO, Byington CL (2008). Pneumococcal necrotizing pneumonia in Utah: does serotype matter? Clin Infect Dis, 46(9), 1346-52. ()
    133. Haddad MB, Porucznik CA, Joyce KE, De AK, Pavia AT, Rolfs RT, Byington CL (2008). Risk factors for pediatric invasive pneumococcal disease in the Intermountain West, 1996-2002. Ann Epidemiol, 18(2), 139-46. ()
    134. Albright FS, Orlando P, Pavia AT, Jackson GG, Cannon Albright LA (2008). Evidence for a heritable predisposition to death due to influenza. J Infect Dis, 197(1), 18-24. ()
    135. Gesteland PH, Samore MH, Pavia AT, Srivastava R, Korgenski K, Gerber K, Daly JA, Mundorff MB, Rolfs RT, James BC, Byington CL (2007). Informing the front line about common respiratory viral epidemics. AMIA Annu Symp Proc, 274-8. ()
    136. Blaschke AJ, Bender J, Byington CL, Korgenski K, Daly J, Petti CA, Pavia AT, Ampofo K (2007). Gordonia species: emerging pathogens in pediatric patients that are identified by 16S ribosomal RNA gene sequencing. Clin Infect Dis, 45(4), 483-6. ()
    137. Ampofo K, Gesteland PH, Bender J, Mills M, Daly J, Samore M, Byington C, Pavia AT, Srivastava R (2006). Epidemiology, complications, and cost of hospitalization in children with laboratory-confirmed influenza infection. Pediatrics, 118(6), 2409-17. ()
    138. Whitley RJ, Bartlett J, Hayden FG, Pavia AT, Tapper M, Monto AS (2006). Seasonal and pandemic influenza: recommendations for preparedness in the United States. J Infect Dis, 194 Suppl 2, S155-61. ()
    139. Hayden FG, Pavia AT (2006). Antiviral management of seasonal and pandemic influenza. J Infect Dis, 194 Suppl 2, S119-26. ()
    140. Oakes RS, Siegler RL, McReynolds MA, Pysher T, Pavia AT (2006). Predictors of fatality in postdiarrheal hemolytic uremic syndrome. Pediatrics, 117(5), 1656-62. ()
    141. Byington CL, Korgenski K, Daly J, Ampofo K, Pavia A, Mason EO (2006). Impact of the pneumococcal conjugate vaccine on pneumococcal parapneumonic empyema. Pediatr Infect Dis J, 25(3), 250-4. ()
    142. Park AH, Muntz HR, Smith ME, Afify Z, Pysher T, Pavia A (2005). Pediatric invasive fungal rhinosinusitis in immunocompromised children with cancer. Otolaryngol Head Neck Surg, 133(3), 411-6. ()
    143. Hardin DS, Rice J, Doyle ME, Pavia A (2005). Growth hormone improves protein catabolism and growth in prepubertal children with HIV infection. Clin Endocrinol (Oxf), 63(3), 259-62. ()
    144. Byington CL, Samore MH, Stoddard GJ, Barlow S, Daly J, Korgenski K, Firth S, Glover D, Jensen J, Mason EO, Shutt CK, Pavia AT (2005). Temporal trends of invasive disease due to Streptococcus pneumoniae among children in the intermountain west: emergence of nonvaccine serogroups. Clin Infect Dis, 41(1), 21-9. ()
    145. Haddad MB, Hill MB, Pavia AT, Green CE, Jumaan AO, De AK, Rolfs RT (2005). Vaccine effectiveness during a varicella outbreak among schoolchildren: Utah, 2002-2003. Pediatrics, 115(6), 1488-93. ()
    146. Mertz GJ, Miedzinski L, Goade D, Pavia AT, Hjelle B, Hansbarger CO, Levy H, Koster FT, Baum K, Lindemulder A, Wang W, Riser L, Fernandez H, Whitley RJ, Collaborative Antiviral Study Group (2004). Placebo-controlled, double-blind trial of intravenous ribavirin for the treatment of hantavirus cardiopulmonary syndrome in North America. Clin Infect Dis, 39(9), 1307-13. ()
    147. Rocholl C, Gerber K, Daly J, Pavia AT, Byington CL (2004). Adenoviral infections in children: the impact of rapid diagnosis. Pediatrics, 113(1 Pt 1), e51-6. ()
    148. Siegler RL, Sherbotie JR, Denkers ND, Pavia AT (2003). Clustering of post-diarrheal (Shiga toxin-mediated) hemolytic uremic syndrome in families. Clin Nephrol, 60(2), 74-9. ()
    149. van Leeuwen R, Katlama C, Murphy RL, Squires K, Gatell J, Horban A, Clotet B, Staszewski S, van Eeden A, Clumeck N, Moroni M, Pavia AT, Schmidt RE, Gonzalez-Lahoz J, Montaner J, Antunes F, Gulick R, Bnhegyi D, van der Valk M, Reiss P, van Weert L, van Leth F, Johnson VA, Sommadossi JP, Lange JM (2003). A randomized trial to study first-line combination therapy with or without a protease inhibitor in HIV-1-infected patients. AIDS, 17(7), 987-99. ()
    150. Byington CL, Rittichier KK, Bassett KE, Castillo H, Glasgow TS, Daly J, Pavia AT (2003). Serious bacterial infections in febrile infants younger than 90 days of age: the importance of ampicillin-resistant pathogens. Pediatrics, 111(5 Pt 1), 964-8. ()
    151. Byington CL, Castillo H, Gerber K, Daly JA, Brimley LA, Adams S, Christenson JC, Pavia AT (2002). The effect of rapid respiratory viral diagnostic testing on antibiotic use in a children's hospital. Arch Pediatr Adolesc Med, 156(12), 1230-4. ()
    152. Siegler RL, Pavia AT, Sherbotie JR (2002). Recurrent hemolytic uremic syndrome. Clin Pediatr (Phila), 41(9), 705-9. ()
    153. Bonkowsky JL, Christenson JC, Nixon GW, Pavia AT (2002). Cerebral aneurysms in a child with acquired immune deficiency syndrome during rapid immune reconstitution. J Child Neurol, 17(6), 457-60. ()
    154. Byington CL, Spencer LY, Johnson TA, Pavia AT, Allen D, Mason EO, Kaplan S, Carroll KC, Daly JA, Christenson JC, Samore MH (2002). An epidemiological investigation of a sustained high rate of pediatric parapneumonic empyema: risk factors and microbiological associations. Clin Infect Dis, 34(4), 434-40. ()
    155. Chapman LE, Ellis BA, Koster FT, Sotir M, Ksiazek TG, Mertz GJ, Rollin PE, Baum KF, Pavia AT, Christenson JC, Rubin PJ, Jolson HM, Behrman RE, Khan AS, Bell LJ, Simpson GL, Hawk J, Holman RC, Peters CJ, Ribavirin Study Group (2002). Discriminators between hantavirus-infected and -uninfected persons enrolled in a trial of intravenous ribavirin for presumptive hantavirus pulmonary syndrome. Clin Infect Dis, 34(3), 293-304. ()
    156. Adderson EE, Byington CL, Spencer L, Kimball A, Hindiyeh M, Carroll K, Mottice S, Korgenski EK, Christenson JC, Pavia AT (2001). Invasive serotype a Haemophilus influenzae infections with a virulence genotype resembling Haemophilus influenzae type b: emerging pathogen in the vaccine era? Pediatrics, 108(1), E18. ()
    157. Staes CJ, Schlenker TL, Risk I, Cannon KG, Harris H, Pavia AT, Shapiro CN, Bell BP (2000). Sources of infection among persons with acute hepatitis A and no identified risk factors during a sustained community-wide outbreak. Pediatrics, 106(4), E54. ()
    158. Davey RT Jr, Murphy RL, Graziano FM, Boswell SL, Pavia AT, Cancio M, Nadler JP, Chaitt DG, Dewar RL, Sahner DK, Duliege AM, Capra WB, Leong WP, Giedlin MA, Lane HC, Kahn JO (2000). Immunologic and virologic effects of subcutaneous interleukin 2 in combination with antiretroviral therapy: A randomized controlled trial. JAMA, 284(2), 183-9. ()
    159. Adderson E, Pavia A, Christenson J, Davis R, Leonard R, Carroll K (2000). A community pseudo-outbreak of invasive Staphylococcus aureus infection. Diagn Microbiol Infect Dis, 37(3), 219-21. ()
    160. Adderson EE, Pavia AT, Christenson JC, Davis R, Leonard RB, Carroll KC (2000). A community pseudo-outbreak of invasive Staphylococcus aureus infection. Diagn Microbiol Infect Dis, 37, 219-21.
    161. Pavia AT (1999). Advances in antimicrobial therapy. Semin Pediatr Neurol, 6(4), 288-98. ()
    162. Christenson JC, Byington C, Korgenski EK, Adderson EE, Bruggers C, Adams RH, Jenkins E, Hohmann S, Carroll K, Daly JA, Pavia AT (1999). Bacillus cereus infections among oncology patients at a children's hospital. Am J Infect Control, 27(6), 543-6. ()
    163. Adderson EE, Pappin A, Pavia AT (1998). Spontaneous intestinal perforation in premature infants: a distinct clinical entity associated with systemic candidiasis. J Pediatr Surg, 33(10), 1463-7. ()
    164. Ioannidis JP, Collier AC, Cooper DA, Corey L, Fiddian AP, Gazzard BG, Griffiths PD, Contopoulos-Ioannidis DG, Lau J, Pavia AT, Saag MS, Spruance SL, Youle MS (1998). Clinical efficacy of high-dose acyclovir in patients with human immunodeficiency virus infection: a meta-analysis of randomized individual patient data. J Infect Dis, 178(2), 349-59. ()
    165. Raboud JM, Montaner JS, Rae S, Kahn J, Hammer SM, Katzenstein DA, Pavia A, Dolin R, Hughes MD, Cross A, Beltangady M, Gatell J, Dunkle L, Smaldone L (1997). Meta-analysis of five randomized controlled trials comparing continuation of zidovudine versus switching to didanosine in HIV-infected individuals. Antivir Ther, 2(4), 237-47. ()
    166. Deeks SG, Collier A, Lalezari J, Pavia A, Rodrigue D, Drew WL, Toole J, Jaffe HS, Mulato AS, Lamy PD, Li W, Cherrington JM, Hellmann N, Kahn J (1997). The safety and efficacy of adefovir dipivoxil, a novel anti-human immunodeficiency virus (HIV) therapy, in HIV-infected adults: a randomized, double-blind, placebo-controlled trial. J Infect Dis, 176(6), 1517-23. ()
    167. Christenson JC, Pavia AT, Seskin K, Brockmeyer D, Korgenski EK, Jenkins E, Pierce J, Daly JA (1997). Meningitis due to Ochrobactrum anthropi: an emerging nosocomial pathogen. A report of 3 cases. Pediatr Neurosurg, 27(4), 218-21. ()
    168. Meadows KP, Tyring SK, Pavia AT, Rallis TM (1997). Resolution of recalcitrant molluscum contagiosum virus lesions in human immunodeficiency virus-infected patients treated with cidofovir. Arch Dermatol, 133(8), 987-90. ()
    169. Litwin CM, Leonard RB, Carroll KC, Drummond WK, Pavia AT (1997). Characterization of endemic strains of Shigella sonnei by use of plasmid DNA analysis and pulsed-field gel electrophoresis to detect patterns of transmission. J Infect Dis, 175(4), 864-70. ()
    170. Spruance SL, Pavia AT, Mellors JW, Murphy R, Gathe J Jr, Stool E, Jemsek JG, Dellamonica P, Cross A, Dunkle L (1997). Clinical efficacy of monotherapy with stavudine compared with zidovudine in HIV-infected, zidovudine-experienced patients. A randomized, double-blind, controlled trial. Bristol-Myers Squibb Stavudine/019 Study Group. Ann Intern Med, 126(5), 355-63. ()
    171. Siegler RL, Pavia AT, Cook JB (1997). Hemolytic-uremic syndrome in adolescents. Arch Pediatr Adolesc Med, 151(2), 165-9. ()
    172. Fischer PR, Christenson JC, Pavia AT, Orme GA (1997). Post-operative Mycobacterium flavescens infection in a child. Infect Dis Clin Pract (Baltim Md), 6, 263-5.
    173. Siegler RL, Pavia AT, Hansen FL, Christofferson RD, Cook JB (1996). Atypical hemolytic-uremic syndrome: a comparison with postdiarrheal disease. J Pediatr, 128(4), 505-11. ()
    174. Chang HJ, Christenson JC, Pavia AT, Bobrin BD, Bland LA, Carson LA, Arduino MJ, Verma P, Aguero SM, Carroll K, Jenkins E, Daly JA, Woods ML, Jarvis WR (1996). Ochrobactrum anthropi meningitis in pediatric pericardial allograft transplant recipients. J Infect Dis, 173(3), 656-60. ()
    175. Christenson JC, Pavia AT, Woods ML, Carroll KC, Nichols C (1996). Ochrabactrum anthropi meningitis from cadaveric pericardial dural gafts. 45, 671-673.
    176. Riley DK, Pavia AT, Beatty PG, Denton D, Carroll KC (1995). Surveillance cultures in bone marrow transplant recipients: worthwhile or wasteful? Bone Marrow Transplant, 15(3), 469-73. ()
    177. Riley DK, Pavia AT, Beatty PG, Petersen FB, Spruance JL, Stokes R, Evans TG (1994). The prophylactic use of low-dose amphotericin B in bone marrow transplant patients. Am J Med, 97(6), 509-14. ()
    178. Kriesel JD, Adderson EE, Gooch WM 3rd, Pavia AT (1994). Invasive sinonasal disease due to Scopulariopsis candida: case report and review of scopulariopsosis. Clin Infect Dis, 19(2), 317-9. ()
    179. Siegler RL, Pavia AT, Christofferson RD, Milligan MK (1994). A 20-year population-based study of postdiarrheal hemolytic uremic syndrome in Utah. Pediatrics, 94(1), 35-40. ()
    180. Spruance SL, Pavia AT, Peterson D, Berry A, Pollard R, Patterson TF, Frank I, Remick SC, Thompson M, MacArthur RD, Morey GE, Ramirez-Ronda CH, Bernstein BM, Sweet DE, Crane L, Peterson EA, Pachucki CT, Green SL, Brand J, Rios A, Dunkle LM, Cross A, Brown MJ, Ingraham P, Gugliotti R, Schindzielorz AH, Smaldone L (1994). Didanosine compared with continuation of zidovudine in HIV-infected patients with signs of clinical deterioration while receiving zidovudine. A randomized, double-blind clinical trial. The Bristol-Myers Squibb AI454-010 Study Group. Ann Intern Med, 120(5), 360-8. ()
    181. Rocha BH, Christenson JC, Pavia A, Evans RS, Gardner RM (1994). Computerized detection of nosocomial infections in newborns. Proc Annu Symp Comput Appl Med Care, 684-8. ()
    182. Rocha BHSC, Christenson JC, Pavia AT, Evans RS, Gardner RM (1994). Computerized detection of nosocomial infections in newborns. J Am Med Inform Assoc, S684-S688.
    183. Pavia AT, Benyo M, Niler L, Risk I (1993). Partner notification for control of HIV: results after 2 years of a statewide program in Utah. Am J Public ǿմý, 83(10), 1418-24. ()
    184. Holmberg RE Jr, Pavia AT, Montgomery D, Clark JM, Eggert LD (1993). Nosocomial Legionella pneumonia in the neonate. Pediatrics, 92(3), 450-3. ()
    185. Struwe M, Kaempfer SH, Geiger CJ, Pavia AT, Plasse TF, Shepard KV, Ries K, Evans TG (1993). Effect of dronabinol on nutritional status in HIV infection. Ann Pharmacother, 27(7-8), 827-31. ()
    186. Pavia AT, Long EG, Ryder RW, Nsa W, Puhr ND, Wells JG, Martin P, Tauxe RV, Griffin PM (1992). Diarrhea among African children born to human immunodeficiency virus 1-infected mothers: clinical, microbiologic and epidemiologic features. Pediatr Infect Dis J, 11(12), 996-1003. ()
    187. Woodruff BA, Pavia AT, Blake PA (1991). A new look at typhoid vaccination. Information for the practicing physician. JAMA, 265(6), 756-9. ()
    188. Barrett TJ, Green JH, Griffin PM, Pavia AT, Ostroff SM, Wachsmuth IK (1991). Enzyme-linked immunosorbent assays for detecting antibodies to Shiga-like toxin I, Sigan-like toxin II, and Escherichia coli O157:H7 lipopolysaccharide in human serum. Curr Microbiol, 23, 189-195.
    189. Ponz E, Piera C, Campistol JM, Lomea F, Pava A, Herranz R, Muoz Gmez J, Setoain J, Revert L (1990). [The gammagraphic diagnosis of dialysis-associated amyloidosis with beta 2-microglobulin-I-131. Preliminary results]. Med Clin (Barc), 95(14), 538-9. ()
    190. Pavia AT, Nielsen L, Armington L, Thurman DJ, Tierney E, Nichols CR (1990). A community-wide outbreak of hepatitis A in a religious community: impact of mass administration of immune globulin. Am J Epidemiol, 131(6), 1085-93. ()
    191. Pavia AT, Nichols CR, Green DP, Tauxe RV, Mottice S, Greene KD, Wells JG, Siegler RL, Brewer ED, Hannon D (1990). Hemolytic-uremic syndrome during an outbreak of Escherichia coli O157:H7 infections in institutions for mentally retarded persons: clinical and epidemiologic observations. J Pediatr, 116(4), 544-51. ()
    192. Pavia AT, Shipman LD, Wells JG, Puhr ND, Smith JD, McKinley TW, Tauxe RV (1990). Epidemiologic evidence that prior antimicrobial exposure decreases resistance to infection by antimicrobial-sensitive Salmonella. J Infect Dis, 161(2), 255-60. ()
    193. Lowry PW, Pavia AT, McFarland LM, Peltier BH, Barrett TJ, Bradford HB, Quan JM, Lynch J, Mathison JB, Gunn RA (1989). Cholera in Louisiana. Widening spectrum of seafood vehicles. Arch Intern Med, 149(9), 2079-84. ()
    194. Pavia AT, Bryan JA, Maher KL, Hester TR Jr, Farmer JJ 3rd (1989). Vibrio carchariae infection after a shark bite. Ann Intern Med, 111(1), 85-6. ()
    195. Hargrett-Bean NT, Pavia AT, Tauxe RV (1988). Salmonella isolates from humans in the United States, 1984-1986. MMWR CDC Surveill Summ, 37(2), 25-31. ()
    196. Novotny T, Dingman JD, Pavia A (2019). Foodborne Illness Associated with a Pig Roast. J Food Prot, 50(11), 945-947. ()
    197. Chute CG, Baron JA, Plymate SR, Kiel DP, Pavia AT, Lozner EC, OKeefe T, MacDonald GJ (1987). Sex hormones and coronary artery disease. Am J Med, 83(5), 853-9. ()
    198. Pavia AT (1987). Diseases Associated with Raw Oysters. 3, 1.
    199. Pavia AT, Tauxe RV (1987). Traveler's Diarrhea and the Soviet Union. JAMA, 258;1661.
    200. Novotny T, Dingman JD, Pavia AT (1987). Foodborne illness associated with a pig roast. J Food Prot, 50, 945-47.
    201. Pavia AT (1986). Cholera in Louisiana. 35, 687-8.

    Review

    1. Eccles R, Boivin G, Cowling BJ, Pavia A, Selvarangan R (2023). Treatment of COVID-19 symptoms with over the counter (OTC) medicines used for treatment of common cold and flu. [Review]. Clin Infect Pract, 19, 100230. ()
    2. Pavia AT (1994). Approach to food-borne and water-borne illness. [Review]. Semin Pediatr Infect Dis, 5, 222-230.

    Book Chapter

    1. Doby E, Pavia AT (2012). Managing HIV Infection in Children and Adolescents. In Volberding, Greene, Lange, Gallant and Swankambo (Eds.), Sande's HIV and AIDS Medicine (2nd). London: Elsevier.
    2. Pavia AT (2009). Salmonella, Shigella and enteric E. coli infections. In Rudolph C et al (Ed.), Rudolph’s Textbook of Pediatrics (22). New York: McGraw Hill.
    3. Pavia AT (2009). Food-Borne and Water Borne Disease. In Long SS, Prober CG, Pickering LK (Eds.), Principles and Practice of Pediatric Infectious Diseases (3). New York: Churchill Livingstone.
    4. Pavia AT (2009). Food Poisoning. In Schlossberg D (Ed.), Current Therapy of Infectious Disease (3). Philadelphia: Mosby-Year Book.
    5. Pavia AT (2009). Stavudine. In Dolin RD, Masur H, Saag M (Eds.), AIDS Therapy (3). New York: Churchill Livingston.
    6. Pavia AT (2009). Managing HIV infection in children and adolescents. In Sande M, Volberding P, Lange J, Greene W (Eds.), Global HIV/AIDS Medicine (1). Elsevier.
    7. Pavia AT, Zar H (2009). Pediatric HIV Infection. In Global AIDS Learning and Evaluation Network (GALEN). International Association of Physicians in AIDS Care (IAPAC).
    8. Blaschke A, Pavia AT (2009). Infectious Diarrhea. In Wilson, Sande, Henry, Drew, Relman, Steckelberg and Gerberding, (Eds.), Current Diagnosis and Treatment of Infectious Diseases, (2). Lange Medical Books/McGraw Hill.
    9. Pavia AT (2003). Stavudine . In Dolin RD, Masur H, Saag M (Eds.), AIDS Therapy (2nd). Churchill Livingston.
    10. Pavia AT (2003). Infants and Children . In Cohen PT, Sande MA, Volberding PA (Eds.), The AIDS Knowledge Base (4th). Lippincott, Williams, & Wilkins.
    11. Pavia AT (2002). Salmonella, Shigella and enteric E. coli infections. In Rudolph A et al (Ed.), Rudolph's Textbook of Pediatrics.
    12. Pavia AT (2002). Evaluation of the returned traveller: Diarrhea and foodborne illness. In Armstong D and Cohen J (Eds.) (2nd). London: Mosby Inc.
    13. Pavia AT (2001). Food-Borne and Water Borne Disease. In Long SS, Prober CG, Pickering LK (Eds.), Principles and Practice of Pediatric Infectious Diseases (2nd). New York: Churchill Livingstone.
    14. Pavia AT (1999). Evaluation of the returned traveller: Diarrhea and foodborne illness . In Armstrong D and Cohen J (Eds.). London: Mosby Inc.
    15. Pavia AT (1999). Stavudine . In Dolin RD, Masur H, Saag M (Eds.), AIDS Therapy. New York: Churchill Livingston, Inc.
    16. Pavia AT, Christenson JC (1999). Pediatric AIDS. In Sande MA, Volberding PA (Eds.), The Medical Management of AIDS (6th).
    17. Pavia AT (1999). Food Poisoning. In Schlossberg D (Ed.), Current Therapy of Infectious Disease Second Edition. Philadelphia: Mosby-Year Book Inc.
    18. Fischer PR, Christenson JC, Pavia AT (1999). Evaluation of the child returning from travel to a developing country. In Bia F (Ed.).
    19. Tauxe RV, Pavia AT (1998). Salmonellosis: Nontyphoidal. In Evans A and Brachman P (Eds.), Bacterial Infections in Humans (3rd). New York: Plenum.
    20. Pavia AT (1997). Food Poisoning. In Kassirer JP, Greene HL (Eds.), Current Therapy in Adult Medicine. Philadelphia: Mosby-Year Book Inc.
    21. Pavia AT (1996). Food-Borne and Water Borne Disease. In Long SS, Prober CG, Pickering LK (Eds.), Principles and Practice of Pediatric Infectious Diseases (1st). New York: Churchill Livingstone.
    22. Pavia AT (1995). Food Poisoning. In Schlossberg D (Ed.), Current Therapy of Infectious Disease. Philadelphia: Mosby-Year Book Inc.
    23. Pavia AT, Siegler RL, Christofferson R, Milligan M (1994). A 20-Year Population-Based Study of Hemolytic Uremic Syndrome: Evidence for the Importance of Shiga-Like Toxin Producting Escherichia coli. In Karmali MA, Goglio AG (Eds.), Recent Advances in Verocytotoxin-Producing Escherichia coli Infections (pp. 25-28). Amsterdam: Elsevier Science.
    24. Pavia AT, Tauxe RV (1991). Salmonellosis: Nontyphoidal. In Evans A and Brachman P (Eds.), Bacterial Infections in Humans (2nd). New York: Plenum.
    25. Pavia AT, Tauxe RV (1991). Salmonellosis. In Kelley WN (Ed.), Textbook of Internal Medicine (2nd). Philadelphia: JB Lippincott Co.
    26. Pavia AT, Lowry PW, McFarland L, Bradford HB, Cook WL, Wachsmuth IK, Blake PA (1987). Cholera in the United States 1986: The Widening Spectrum. In Advances in Research on Cholera and Related Diarrheas: Proceedings of the Twenty-Third Joint Cholera Conference 1987. Tokyo: KTK Publishers.

    Editorial

    1. Pavia AT (2016). Influenza Vaccine Effectiveness: Mysteries, Enigmas, and a Few Clues. J Infect Dis, 213(10), 1521-2. ()
    2. Frank GM, Adalja A, Barbour A, Casadevall A, Dormitzer PR, Duchin J, Hayden FG, Hirsch MS, Hynes NA, Lipsitch M, Pavia AT, Relman DA (2016). Infectious Diseases Society of America and Gain-of-Function Experiments With Pathogens Having Pandemic Potential. J Infect Dis, 213(9), 1359-61. ()
    3. Jain S, Pavia AT (2016). Editorial Commentary: The Modern Quest for the "Holy Grail" of Pneumonia Etiology. Clin Infect Dis, 62(7), 826-8. ()
    4. Hersh AL, Pavia AT (2015). Comparative Effectiveness Research in Pediatric Infectious Diseases. J Pediatric Infect Dis Soc, 4(1), 28-9. ()
    5. Bessesen MT, Savor-Price C, Simberkoff M, Reich NG, Pavia AT, Radonovich LJ (2013). N95 respirators or surgical masks to protect healthcare workers against respiratory infections: are we there yet? Am J Respir Crit Care Med, 187(9), 904-5. ()
    6. Pavia AT (2012). Editorial commentary: What did we learn from the emergency use authorization of peramivir in 2009? Clin Infect Dis, 55(1), 16-8. ()
    7. Salmon DA, Pavia A, Gellin B (2011). Editors' introduction: Vaccine safety throughout the product life cycle. Pediatrics, 127 Suppl 1, S1-4. ()
    8. Pavia AT (2010). Mandate to protect patients from health care-associated influenza. Clin Infect Dis, 50(4), 465-7. ()
    9. Pavia AT (2007). Germs on a plane: aircraft, international travel, and the global spread of disease. J Infect Dis, 195(5), 621-2. ()
    10. Pavia AT (2004). Editorial comment: fixed-dose combination formulations are the answer, what was the question? AIDS Read, 14(10), 549. ()
    11. McGee ZA, Pavia AT (1991). Is the concept, "agents of sexually transmitted disease" still valid? Sex Transm Dis, 18(2), 69-71. ()

    Letter

    1. Pavia AT, Ison MG, Wolfe CR, Uyeki TM (2019). Response to Apewokin and Onyishi. [Letter to the editor]. Clin Infect Dis, 70(12), 2749-2750. ()
    2. Uyeki TM, Ison MG, Wolfe CR, Pavia AT (2020). Reply to Verweij et al. [Letter to the editor]. Clin Infect Dis, 70(2), 350-351. ()
    3. Stenehjem E, Hersh AL, Pavia AT (2017). Reply to Buetti et al. [Letter to the editor]. Clin Infect Dis, 64(7), 985-986. ()
    4. Stockmann C, Sherwin CM, Knackstedt ED, Hersh AL, Pavia AT, Spigarelli MG (2016). Therapeutic Drug Monitoring of Ganciclovir Treatment for Cytomegalovirus Infections Among Immunocompromised Children. [Letter to the editor]. J Pediatric Infect Dis Soc, 5(2), 231-232. ()
    5. Stockmann C, Ampofo K, Hersh AL, Bennett TD, Boulton R, Plant P, Byington CL, Pavia AT (2013). Local ǿմý Department Influenza Surveillance Estimates and Projections of Peak Pediatric Intensive Care Unit Occupancy During the 2009 Influenza A Pandemic. [Letter to the editor]. J Pediatric Infect Dis Soc, 2(4), 405-6. ()
    6. Blaschke AJ, Byington CL, Ampofo K, Pavia AT, Heyrend C, Rankin SC, McGowan KL, Harris MC, Shah SS (2013). Species-specific PCR improves detection of bacterial pathogens in parapneumonic empyema compared with 16S PCR and culture. [Letter to the editor]. Pediatr Infect Dis J, 32(3), 302-3. ()
    7. Bonkowsky J, Pavia A (2007). Cerebral vasculopathy with aneurysm formation in HIV-infected young adults. [Letter to the editor]. Neurology, 68(8), 623; author reply 623. ()
    8. Pavia AT, Riley DK (1993). Fluconazole prophylaxis in patients with leukemia. [Letter to the editor]. Ann Intern Med, 119(9), 951-2. ()
    9. Pavia AT, Campbell JF, Blake PA, Smith JD, McKinley TW, Martin DL (1987). Cholera from raw oysters shipped interstate. [Letter to the editor]. JAMA, 258(17), 2374. ()
    10. Pavia AT (1986). Salmonellosis in a School System [Letter to the editor]. 36, 74-75.

    Newspaper

    1. Pavia AT (June 8, 2016). Op-ed: Hatch bill is PATH forward to developing new antibiotics. Salt Lake Tribune.

    Other

    1. Turer RW, Gradwohl S, Stassun J, Johnson J, Slagle J, Reale C, Beebe R, Nian H, Zhu Y, Albert D, Coffman T, Alaw H, Wilson T, Just S, Peguillan P, Freeman H, Arnold DH, Martin JM, Suresh S, Coglio S, Hixon R, Ampofo K, Pavia AT, Weinger M, Williams D, Ozdas Weitkamp A (2024). User-Centered Design and Implementation of an Interoperable FHIR Application for Pediatric Pneumonia Prognostication in a Randomized Trial. Appl Clin Inform. Germany. ()
    2. Duong KNC, Le LM, Veettil SK, Saidoung P, Wannaadisai W, Nelson RE, Friedrichs M, Jones BE, Pavia AT, Jones MM, Samore MH, Chaiyakunapruk N (2023). Disparities in COVID-19 related outcomes in the United States by race and ethnicity pre-vaccination era: an umbrella review of meta-analyses. Front Public ǿմý (11, p. 1206988). Switzerland. ()
    3. Samore MH, Looney A, Orleans B, Greene T, Seegert N, Delgado JC, Presson A, Zhang C, Ying J, Zhang Y, Shen J, Slev P, Gaulin M, Yang MJ, Pavia AT, Alder SC (2021). Probability-Based Estimates of Severe Acute Respiratory Syndrome Coronavirus 2 Seroprevalence and Detection Fraction, Utah, USA. Emerg Infect Dis (27(11), pp. 2786-2794). United States. ()
    4. Kim L, Rha B, Abramson JS, Anderson LJ, Byington CL, Chen GL, DeVincenzo J, Edwards KM, Englund JA, Falsey AR, Griffin MR, Karron RA, Martin KG, Meissner HC, Munoz FM, Pavia AT, Piedra PA, Schaffner W, Simes EAF, Singleton R, Talbot HK, Walsh EE, Zucker JR, Gerber SI (2017). Identifying Gaps in Respiratory Syncytial Virus Disease Epidemiology in the United States Prior to the Introduction of Vaccines. Clin Infect Dis (65(6), pp. 1020-1025). United States. ()
    5. Hendricks KA, Wright ME, Shadomy SV, Bradley JS, Morrow MG, Pavia AT, Rubinstein E, Holty JE, Messonnier NE, Smith TL, Pesik N, Treadwell TA, Bower WA, Workgroup on Anthrax Clinical Guidelines (2014). Centers for disease control and prevention expert panel meetings on prevention and treatment of anthrax in adults. Emerg Infect Dis (20(2)). United States. ()
    6. Pavia AT (1989). Legionella: Review of a Continuing Nosocomial Problem. Rocky Mountain Infection Control Bulletin.

  • News & Podcasts

    News